BPC-157 and TB-500 represent the most extensively co-studied regenerative peptide pairing available to laboratories in Ireland and a research stack combining the gastric pentadecapeptide BPC-157, a 15-amino acid partial sequence of Body Protection Compound isolated from human gastric juice with potent and systemically active tissue repair, cytoprotective, and angiogenic properties, with TB-500, a synthetic analogue of the actin-sequestering thymosin beta-4 peptide that promotes cell migration, angiogenesis, and tissue remodelling through G-actin binding and downstream signalling through the PI3K/Akt pathway, producing a research combination whose complementary and potentially synergistic mechanisms across wound healing, tendon and ligament repair, muscle regeneration, neuroregeneration, anti-inflammatory biology, and vascular repair make it the most widely studied peptide pairing in pre-clinical regenerative biology research, Researchers and institutions across Ireland can source verified, research-grade BPC-157 5mg and TB-500 5mg directly from our Irish peptide supply, with domestic-speed dispatch and complete batch documentation for each compound
and the Brain Korea 21 PLUS program of the Korean Ministry of Education, Science and Technology
It contains a domain responsible for interacting with RAB11 family members (including RAB11A, RAB11B and RAB25) and a C2 domain that has been shown to bind to membrane lipids such as phosphatidic acid
Genetics Severe elevations of Hcy concentration in plasma is rare and often caused by homozygous mutations in enzymes involved in its metabolism, such as MS, methylene tetrahydrofolate reductase, and CBS
